2-(furfuryl-methyl-amino)-ethanol | 17254-98-7

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2-(furfuryl-methyl-amino)-ethanol
• 英文别名: 2-(Furfuryl-methyl-amino)-aethanol；2-(Furan-2-ylmethyl-methyl-amino)-ethanol；2-[furan-2-ylmethyl(methyl)amino]ethanol
• CAS: 17254-98-7
• 化学式: C₈H₁₃NO₂
• 分子量: 155.197
• InChiKey: IOZBNKPLJBTBQQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  11
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  36.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  2-(Furan-2-yl)-3-methyl-1,3-oxazolidine 在 [,14-bis(diphenylphosphino)butane] (1,5-cyclooctadiene)rhodium(I) tetrafluoroborate 氢气 作用下， 以 甲醇 为溶剂， 20.0 ℃ 、5.2 MPa 条件下， 反应 2.0h， 生成 2-(furfuryl-methyl-amino)-ethanol
  参考文献：
  名称：

  环状N,O-缩醛均相催化氢解合成N-(二烷基氨基烷基)醇

  摘要：

  据报道，1,3-恶唑烷的均相催化氢化得到不对称取代的 2-N-(二烷基氨基)乙醇，这首次表明基于螯合二膦的 Rh(I) 催化剂可能对该反应有利。

  DOI：

  10.1055/s-2002-20039

文献信息

• [EN] 5- (4- (HALOALKOXY) PHENYL) PYRIMIDINE-2-AMINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS<br/>[FR] COMPOSÉS ET COMPOSITIONS DE 5- (4- (HALOALKOXY) PHÉNYL) PYRIMIDINE-2-AMINE UTILISÉS COMME INHIBITEURS DE KINASES
  申请人：IRM LLC

  公开号：WO2009026276A1

  公开（公告）日：2009-02-26

  The invention provides compounds of formula (1) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit, PDGFRα, PDGFRβ, CSF1R, AbI, BCR-AbI, CSK, JNK1, JNK2, p38, p70S6K, TGFβ, SRC, EGFR, trkB, FGFR3. Fes, Lck, Syk, RAF, MKK4, MKK6, SAPK2β, BRK, Fms, KDR, c-rapor b-raf kinases.

  该发明提供了式（1）的化合物及其制药组合物，可用作蛋白激酶抑制剂，以及使用这些化合物治疗、改善或预防与异常或调节的激酶活性相关的疾病的方法。在某些实施方式中，该发明提供了使用这些化合物来治疗、改善或预防涉及c-kit、PDGFRα、PDGFRβ、CSF1R、AbI、BCR-AbI、CSK、JNK1、JNK2、p38、p70S6K、TGFβ、SRC、EGFR、trkB、FGFR3、Fes、Lck、Syk、RAF、MKK4、MKK6、SAPK2β、BRK、Fms、KDR、c-rapor、b-raf激酶的疾病或紊乱的方法。
• Multimodal Anion Exchange Matrices
  申请人：GE HEALTHCARE BIO-SCIENCES AB

  公开号：US20150299248A1

  公开（公告）日：2015-10-22

  The invention discloses a separation matrix which comprises a plurality of separation ligands, defined by the formula R 1 -L 1 -N(R 3 )-L 2 -R, immobilized on a support, wherein R 1 is a five- or six-membered, substituted or non-substituted ring structure or a hydroxyethyl or hydroxypropyl group; L 1 is either a methylene group or a covalent bond; R 2 is a five- or six-membered, substituted or non-substituted ring structure; L 2 is either a methylene group or a covalent bond; R 3 is a methyl group; and wherein if R 1 is a hydroxyethyl group and L 1 is a covalent bond, R 2 is a substituted aromatic ring structure or a substituted or non-substituted aliphatic ring structure.

  该发明揭示了一种分离基质，包括多个分离配体，其由公式R1-L1-N(R3)-L2-R所定义，固定在支撑物上，其中R1是一个五元或六元的取代或非取代环结构或一个羟乙基或羟丙基基团；L1是一个亚甲基基团或一个共价键；R2是一个五元或六元的取代或非取代环结构；L2是一个亚甲基基团或一个共价键；R3是一个甲基基团；如果R1是一个羟乙基基团且L1是一个共价键，则R2是一个取代芳香环结构或一个取代或非取代脂环结构。
• Multimodal anion exchange matrices
  申请人：GE Healthcare BioProcess R&D AB

  公开号：US10815269B2

  公开（公告）日：2020-10-27

  The invention discloses a separation matrix which comprises a plurality of separation ligands, defined by the formula R1-L1-N(R3)-L2-R, immobilized on a support, wherein R1 is a five- or six-membered, substituted or non-substituted ring structure or a hydroxyethyl or hydroxypropyl group; L1 is either a methylene group or a covalent bond; R2 is a five-or six-membered, substituted or non-substituted ring structure; L2 is either a methylene group or a covalent bond; R3 is a methyl group; and wherein if R1 is a hydroxyethyl group and L1 is a covalent bond, R2 is a substituted aromatic ring structure or a substituted or non-substituted aliphatic ring structure.

  本发明公开了一种分离基质，它包括固定在支持物上的由式 R1-L1-N(R3)-L2-R 定义的多个分离配体，其中 R1 是五元或六元、取代或非取代的环结构或羟乙基或羟丙基；L1 是亚甲基或共价键；R2 是五元或六元、取代或非取代的环结构；L2 是亚甲基或共价键；R3 是甲基；如果 R1 是羟乙基，L1 是共价键，则 R2 是取代的芳环结构或取代或非取代的脂环结构。
• The functionalisation of electron rich aromatic compounds with 1,3-oxazolidines and 1,3-dimethylimidazolidine
  作者：Harry Heaney、George Papageorgiou、Robert F. Wilkins

  DOI：10.1016/s0040-4020(97)00922-8

  日期：1997.10

  N-Phenyl- and N-alkyl-oxazolidines react with alkyl chlorosilanes in the presence of electron rich aromatic compounds with the formation of the expected Mannich bases: 2-methoxycarbonyl-3-methyloxazolidine also reacts with 2-methylfuran in the presence of thionyl chloride to give an a-amino acid derivative: the iminium salt derived from 1,3-dimethylimidazolidine was also shown to react with 2-methylfuran. (C) 1997 Elsevier Science Ltd.
• Mannich reactions of oxazolidines
  作者：Robin A. Fairhurst、Harry Heaney、George Papageorgiou、Robert F. Wilkins、Stephen C. Eyley

  DOI：10.1016/s0040-4039(00)99485-1

  日期：1989.1